Indian Diabetes Market 2022-2028

The Indian Diabetes Market is Estimated to Grow With the CAGR of 20.5% During the Period 2017-2022

Indian Diabetes Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report by Disease Type (Type 1 Diabetes, Type 2 Diabetes, and Gestational), by Drug Type (Oral anti-diabetic Drugs, Non-Insulin Injectable drugs, and Combination Drugs), and by Device Type (Blood Glucose Monitoring Devices, Blood Glucose Strips, Insulin devices, and Others)Forecast Period (2022-2028)

The Indian diabetes diagnosis and therapeutics market is anticipated to grow at a CAGR of 7% during the forecast period. The growth of the Indian diabetes diagnosis and therapeutics market during the forecast period can be attributed to the integration of the healthcare sector and information technology which has led to the development of innovative products. Additionally, the presence of major players such as Merck and Sanofi is propelling the market growth during the forecast period.

The Indian diabetes diagnosis and therapeutics market is segmented based on disease type, drug type, and device type. Based on the disease type, the market is further classified into Type 1 Diabetes, Type 2 Diabetes, and gestational. Based on drug type, the market is further segmented into oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs. Based on the device type, the market is further segregated into blood glucose monitoring devices, blood glucose strips, insulin devices, and others (lancets).Among these, the oral anti-diabetic drugs segment is projected to show lucrative growth during the forecast period owing to the high prevalence of type-2 diabetes and affordability as well as ease of use of oral-antidiabetic drugs (OAD) medication.

The major companies serving the Indian diabetes diagnosis and therapeutics market include Elli Lilly and Co., Merck & Co., Inc., Novartis International AG, Pfizer Inc., and Glenmark Pharmaceuticals Ltd., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, partnerships, geographical expansion, and collaborations to stay competitive in the market. For instance, in January2019, Medtronics and Eris Lifesciences launched Guardian Connect in India. Guardian Connect is a Continuous Glucose Monitoring System connected with smartphone displays for a real-time data viewing of glucose levels, without a separate hardware monitor.

Research Methodology

The market study of the Indian diabetes diagnosis and therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Indian Diabetes Diagnosis and Therapeutics Market research and analysis by Disease Type.
2. Indian Diabetes Diagnosis and Therapeutics Market Research and Analysis by Drug Type.
3. Indian Diabetes Diagnosis and Therapeutics Market Research and Analysis by Device Type.

The Report Covers

• Comprehensive research methodology of the Indian diabetes diagnosis and therapeutics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian diabetes diagnosis and therapeutics market.
• Insights about market determinants that are stimulating the Indian diabetes diagnosis and therapeutics market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.